Loading…
Loading…
As of 20 Nov 2026: Choksi Asia ₹208.70 (m-cap ₹119 Cr, P/E 24.3) vs KMS Medisurgi ₹132.45 (m-cap ₹43.71 Cr). Compare ROE, ROCE, growth, debt, dividends and 1-year returns.
As of · NSE prices; ratios from company filings
| Metric | Choksi Asia | KMS Medisurgi |
|---|---|---|
| Share price | ₹208.70 | ₹132.45 |
| Day change | +0.97% | 0.00% |
| Market cap | ₹119 Cr | ₹43.71 Cr |
| P/EPrice ÷ trailing 12-month earnings per share; blank for a loss. | 24.3 | — |
| P/BPrice ÷ book value per share. | 2.7 | 5.4 |
| ROEReturn on equity. | 15.6% | 3.1% |
| ROCEReturn on capital employed. | 18.5% | 5.2% |
| Sales growth (3Y CAGR) | 300.0% | 3.5% |
| Profit growth (3Y CAGR) | 136.0% | -24.0% |
| Debt to equity | 0.05 | 0.09 |
| Dividend yield | 0.00% | 0.04% |
| 1-year price return | +81.0% | — |
| Promoter holding | 71.2% | 74.4% |
| Industry | Medical Equipment & Supplies | Medical Equipment & Supplies |
Open in the compare tool for price charts from one month to five years, scorecards and more companies.
Each line states which company has the higher or lower figure; none of them is a recommendation.
Choksi Asia Ltd is larger, with a market cap of ₹119 Cr against ₹43.71 Cr for KMS Medisurgi Ltd as of 20 Nov 2026 — about 2.7 times the size.
KMS Medisurgi Ltd has no meaningful P/E right now (a loss over the last twelve months, or no reported earnings), so the two cannot be compared on P/E.
Jivani Markets does not give buy, sell or hold recommendations and is not a SEBI-registered investment adviser or research analyst. The table on this page lays out the facts side by side — price, valuation, returns on capital, growth, debt, dividends and promoter holding — so you can weigh them against your own goals, or with a SEBI-registered adviser.
Prices refresh every few minutes during market hours and ratios update when the companies report results. Each number is the same one shown on the two stock pages.